Compare JOUT & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JOUT | IPSC |
|---|---|---|
| Founded | 1970 | 2019 |
| Country | United States | United States |
| Employees | N/A | 78 |
| Industry | Recreational Games/Products/Toys | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 456.3M | 367.6M |
| IPO Year | 1994 | 2021 |
| Metric | JOUT | IPSC |
|---|---|---|
| Price | $44.24 | $1.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.25 |
| AVG Volume (30 Days) | 36.5K | ★ 386.4K |
| Earning Date | 05-08-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.53% | N/A |
| EPS Growth | N/A | ★ 91.30 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $592,415,000.00 | $109,164,000.00 |
| Revenue This Year | $11.67 | N/A |
| Revenue Next Year | $3.70 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 1556.76 |
| 52 Week Low | $35.65 | $0.44 |
| 52 Week High | $53.54 | $2.97 |
| Indicator | JOUT | IPSC |
|---|---|---|
| Relative Strength Index (RSI) | 38.77 | 41.74 |
| Support Level | $44.08 | $1.92 |
| Resistance Level | $48.02 | $2.39 |
| Average True Range (ATR) | 1.44 | 0.10 |
| MACD | -0.19 | -0.01 |
| Stochastic Oscillator | 3.85 | 7.35 |
Johnson Outdoors Inc is a manufacturer and marketer of branded seasonal, outdoor recreation products used for fishing from a boat, diving, paddling, hiking and camping. The company has four operating segment: Fishing, Camping, Watercraft Recreation, and Diving. It generates maximum revenue from the Fishing segment which produces and markets products under different brands such as Minn Kota electric motors for quiet trolling or primary propulsion, marine battery chargers and shallow water anchors; Humminbird sonar and GPS equipment for fish finding, navigation and marine cartography; and Cannon downriggers for controlled-depth fishing. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe, Canada, and other regions.
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.